| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/MNH.0B013E3283414CA1 |
| P698 | PubMed publication ID | 21088574 |
| P50 | author | Grzegorz Piecha | Q58436053 |
| P2093 | author name string | Eberhard Ritz | |
| Nadezda Koleganova | |||
| P433 | issue | 1 | |
| P921 | main subject | metabolic syndrome | Q657193 |
| obesity | Q12174 | ||
| P304 | page(s) | 44-49 | |
| P577 | publication date | 2011-01-01 | |
| P1433 | published in | Current Opinion in Nephrology and Hypertension | Q15756282 |
| P1476 | title | Is there an obesity-metabolic syndrome related glomerulopathy? | |
| P478 | volume | 20 |
| Q36574746 | Adiponectin promotes functional recovery after podocyte ablation |
| Q57476136 | Albuminuria and glomerular filtration rate in obese children and adolescents |
| Q30251745 | Association between prediabetes and risk of chronic kidney disease: a systematic review and meta-analysis |
| Q91725874 | Celastrol attenuates ox-LDL-induced mesangial cell proliferation via suppressing NLRP3 inflammasome activation |
| Q47099353 | Changes in Proteinuria on the Risk of All-Cause Mortality in People with Diabetes or Prediabetes: A Prospective Cohort Study |
| Q28547970 | Effect of Acetazolamide on Obesity-Induced Glomerular Hyperfiltration: A Randomized Controlled Trial |
| Q37342006 | Effects of high-fat diet and losartan on renal cortical blood flow using contrast ultrasound imaging |
| Q55344755 | Elevated FGF23 Levels in Mice Lacking the Thiazide-Sensitive NaCl cotransporter (NCC). |
| Q55398406 | Glomerular Hyperfiltration as Predictor of Cardiometabolic Risk Factors among Children and Adolescents: The Childhood and Adolescence Surveillance and Prevention of Adult-V Study. |
| Q43229492 | Glomerular homeostasis requires a match between podocyte mass and metabolic load |
| Q36109205 | Growth-dependent podocyte failure causes glomerulosclerosis |
| Q41200646 | Hypertension in pediatric patients with chronic kidney disease: management challenges |
| Q92886447 | Inhibition of prolyl hydroxylase domain (PHD) by JTZ-951 reduces obesity-related diseases in the liver, white adipose tissue, and kidney in mice with a high-fat diet |
| Q38135268 | Is there an obesity-related epidemic of CKD starting already in childhood? |
| Q41557819 | Mast Cell and M1 Macrophage Infiltration and Local Pro-Inflammatory Factors Were Attenuated with Incretin-Based Therapies in Obesity-Related Glomerulopathy |
| Q46408848 | Metabolic and Hormonal Determinants of Glomerular Filtration Rate and Renal Hemodynamics in Severely Obese Individuals |
| Q33903763 | Nephropathy in youth and young adults with type 2 diabetes |
| Q36515043 | Obesity and diabetic kidney disease |
| Q35928484 | Overweight, obesity and intentional weight loss in chronic kidney disease: NHANES 1999-2006. |
| Q35005734 | Proximal tubular hypertrophy and enlarged glomerular and proximal tubular urinary space in obese subjects with proteinuria |
| Q84978209 | The longer-term effects of Roux-en-Y gastric bypass surgery on sodium excretion |
| Q42174540 | The relationship between renal volume and histology in obese and nonobese kidney donors. |
| Q28269939 | Transcriptional and Translational Modulation of myo-Inositol Oxygenase (Miox) by Fatty Acids: IMPLICATIONS IN RENAL TUBULAR INJURY INDUCED IN OBESITY AND DIABETES |
| Q38017161 | Transplantation in obese patient |
| Q38187597 | Treatment strategies to prevent renal damage in hypertensive children |
| Q48196703 | Urinary podocalyxin, the novel biomarker for detecting early renal change in obesity. |
| Q51065487 | [Chronic kidney disease : What is currently available for treatment?] |
Search more.